Are you Dr. Reines?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 11 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
11 W Bridlewood Dr
New Hope, PA 18938Phone+1 215-850-6895Fax+1 215-862-3282
Summary
- Dr. Scott Reines, MD is a board certified psychiatrist in New Hope, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Psychiatry, 1976 - 1979
Albert Einstein College of MedicineClass of 1976
Certifications & Licensure
PA State Medical License 1979 - 2026- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects Start of enrollment: 2015 Dec 01
- A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 2 citationsIV tramadol: A novel option for US patients with acute pain-A review of its pharmacokinetics, abuse potential and clinical safety recordLucy Lu, Mark Harnett, Scott A Reines
Journal of Opioid Management. 2020-07-01 - 26 citationsMisuse of Tramadol in the United States: An Analysis of the National Survey of Drug Use and Health 2002-2017.Scott A Reines, Bonnie Goldmann, Mark Harnett, Lucy Lu
Substance Abuse. 2020-06-03 - 6 citationsComparing the Pharmacokinetics of 2 Novel Intravenous Tramadol Dosing Regimens to Oral Tramadol: A Randomized 3-Arm Crossover Study.Lucy Lu, Michael Ryan, Mark Harnett, George Atiee, Scott A Reines
Clinical Pharmacology in Drug Development. 2020-05-01
Press Mentions
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative PainMay 21st, 2018
Memory Drug Enters Clinical Trial, May Help Treat Cognitive DisordersDecember 30th, 2015
